Aghamohseni et al., 2017 - Google Patents
A semi-empirical glycosylation model of a camelid monoclonal antibody under hypothermia cell culture conditionsAghamohseni et al., 2017
- Document ID
- 30781958268351672
- Author
- Aghamohseni H
- Spearman M
- Ohadi K
- Braasch K
- Moo-Young M
- Butler M
- Budman H
- Publication year
- Publication venue
- Journal of Industrial Microbiology and Biotechnology
External Links
Snippet
The impact of cell culture environment on the glycan distribution of a monoclonal antibody (mAb) has been investigated through a combination of experiments and modeling. A newly developed CHO DUXB cell line was cultivated at two levels of initial Glutamine (Gln) …
- 206010021113 Hypothermia 0 title abstract description 42
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Alhuthali et al. | Osmolality effects on CHO cell growth, cell volume, antibody productivity and glycosylation | |
| Sou et al. | How does mild hypothermia affect monoclonal antibody glycosylation? | |
| Sha et al. | N-glycosylation design and control of therapeutic monoclonal antibodies | |
| Möller et al. | Model-assisted design of experiments as a concept for knowledge-based bioprocess development | |
| McHugh et al. | Effective temperature shift strategy development and scale confirmation for simultaneous optimization of protein productivity and quality in Chinese hamster ovary cells | |
| Aghamohseni et al. | Effects of nutrient levels and average culture pH on the glycosylation pattern of camelid-humanized monoclonal antibody | |
| Karst et al. | Modulation and modeling of monoclonal antibody N‐linked glycosylation in mammalian cell perfusion reactors | |
| Brunner et al. | Investigation of the interactions of critical scale-up parameters (pH, p O2 and p CO2) on CHO batch performance and critical quality attributes | |
| Jiang et al. | pH excursions impact CHO cell culture performance and antibody N-linked glycosylation | |
| Konakovsky et al. | Metabolic control in mammalian fed-batch cell cultures for reduced lactic acid accumulation and improved process robustness | |
| Stepper et al. | Pre-stage perfusion and ultra-high seeding cell density in CHO fed-batch culture: a case study for process intensification guided by systems biotechnology | |
| Jimenez del Val et al. | Dynamics of immature mAb glycoform secretion during CHO cell culture: An integrated modelling framework | |
| Kildegaard et al. | Glycoprofiling effects of media additives on IgG produced by CHO cells in fed‐batch bioreactors | |
| Yang et al. | Addition of valproic acid to CHO cell fed-batch cultures improves monoclonal antibody titers | |
| O'Callaghan et al. | Systems biotechnology of mammalian cell factories | |
| EP2528002B1 (en) | Defined glycoprotein products and related methods | |
| Burleigh et al. | Synergizing metabolic flux analysis and nucleotide sugar metabolism to understand the control of glycosylation of recombinant protein in CHO cells | |
| Aghamohseni et al. | A semi-empirical glycosylation model of a camelid monoclonal antibody under hypothermia cell culture conditions | |
| Borys et al. | Effects of culture conditions on N‐glycolylneuraminic acid (Neu5Gc) content of a recombinant fusion protein produced in CHO cells | |
| Hossler | Protein glycosylation control in mammalian cell culture: past precedents and contemporary prospects | |
| Seo et al. | Effect of culture pH on recombinant antibody production by a new human cell line, F2N78, grown in suspension at 33.0 C and 37.0 C | |
| Bolisetty et al. | Enabling speed to clinic for monoclonal antibody programs using a pool of clones for IND-enabling toxicity studies | |
| WO2008128230A1 (en) | Reference glycoprotein products and related methods | |
| Zhang et al. | Combined effects of glycosylation precursors and lactate on the glycoprofile of IgG produced by CHO cells | |
| Kontoravdi et al. | Development of a dynamic model of monoclonal antibody production and glycosylation for product quality monitoring |